Redcare Pharmacy stock
Price history
+2.67% over the period1 year: from €61.75 (November 20, 2025) to €63.40 (November 20, 2026), +2.67%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | €63.40 |
| October 30, 2026 | €69.60 |
| September 30, 2026 | €73.25 |
| August 31, 2026 | €62.35 |
| July 31, 2026 | €61.40 |
| June 30, 2026 | €65.95 |
| May 29, 2026 | €43.64 |
| April 30, 2026 | €48.40 |
| March 31, 2026 | €37.24 |
| February 27, 2026 | €60.65 |
| January 30, 2026 | €62.55 |
| December 30, 2025 | €65.10 |
| November 28, 2025 | €65.45 |
| November 20, 2025 | €61.75 |
At a glance
The company
Online pharmacy operating across Netherlands, Germany, Italy, Belgium, Switzerland, Austria and France offering prescription and non-prescription pharmaceuticals, beauty and personal care
Latest results
Quarter to September 30, 2026 · EPS -€0.01 (estimate €0.07)
TickerLandia's take on Redcare Pharmacy
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−20.65% from the 52-week high
Analysts · 10 analysts
Average target€91.60+44.48% vs. price
Buy 7 · Hold 3 · Sell 0 · Buy
TickerLandia Fingerprint: Redcare Pharmacy
Compared with similar companies: very low profitability.
Financials and price compared with 130 companies in related industries (retail), worldwide. Momentum and risk compared with 1,160 European stocks.
Pricehigh63
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 49.4 93 EV/EBITDA 52.8 95 Price/book 2.91 44 Price/sales 0.40 20 Profitabilityvery low8
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 21.5% 15 ROE −7.1% 5 Net margin −1.0% 6 Operating margin 0.3% 6 ROA 0.5% 7 Earnings stabilitylow24
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.6% 46 Loss-making yearscounts in reverse: lower means more earnings stability 5 of 5 annual reports 2 Growthhigh63
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) −50.41% 8 Revenue growth (year over year) +17.70% 87 Average revenue growth (3 years) +34.66% 96 Financial strengthlow34
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 1.62 76 Interest coverage −1.01 2 Net debt/EBITDAcounts in reverse: lower means more financial strength 162.1 0 Debt/equitycounts in reverse: lower means more financial strength 0.74 58 Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumstrong69
How the stock has moved compared with the market.
Metric Value Position in group 1-year return +2.67% 41 Distance from 200-day average +8.78% 78 Relative strength (3 months) +4.68% 61 Relative strength (6 months) +36.16% 96 Riskhigh79
How much the price swings.
Metric Value Position in group Volatility (60 days) 67.0% 97 Maximum drawdown (12 months) 56.8% 97 Beta (1 year) 0.66 42
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Redcare Pharmacy is pricier than similar companies
Redcare Pharmacy's Forward P/E: 49.4, +208% against the median of a group of 9 similar companies (16.0).
Compared with 9 similar companies
| Metric | Redcare Pharmacy | Position in the group | Band |
|---|---|---|---|
| Forward P/E | 49.4 | High | |
| Operating margin | 0.3% | Low | |
| ROE | -7.1% | Low | |
| Debt/equity | 0.74 | Middle | |
| Price/book | 2.91 | Middle |
Grey band: the middle half of the group; tick: the median; dot: Redcare Pharmacy. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€846.7M
Latest quarter · Q3 2026
Net income
€800K
Latest quarter · Q3 2026
Quarterly net margin
0.1%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- €1.34B
- EPS
- -€1.69
- Volume
- 33.7K
- Daily trading
- €4.22M
- Dividend yield
- 0.00%
How Redcare Pharmacy is changing
All resultsRevenue grew 24.9% a year on average over the last 5 years
Operating margin rose from −3.9% to −0.7%
Shares outstanding up 39.8% in 5 years
Returns
Redcare Pharmacy returns
€1,000 invested in Redcare Pharmacy 5 years ago, on November 22, 2021, would be worth €425 today: −57.48% in total, −15.74% per year. This is the price return only: dividends are excluded.
| Period | Redcare Pharmacy | DAX | €1,000 becomes |
|---|---|---|---|
| 1 month | −16.52% | −1.98% | €835 |
| 6 months | +36.52% | +0.26% | €1,365 |
| Year to date | −2.61% | +1.28% | €974 |
| 1 year | +2.67% | +6.55% | €1,027 |
| 3 years | −49.46% | — | €505 |
| 5 years | −57.48% | — | €425 |
| 10 years | +124.70% | — | €2,247 |
Over the last 6 months it has done better than 95% of the stocks in the Industrials sector.
Price only, without dividends. Calculate your investment
The chart in detail
Redcare Pharmacy: technical analysis
Redcare Pharmacy shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 74.2% below its all-time closing high (€246.00, February 15, 2021).
- Trend
- No clear trend
- RSI (14 sessions)
- 35
- Between 30 and 70
- vs 200-session average
- +8.78%
Active signals
Close below the low of the previous 20 sessions.
since November 18, 2026
Support and resistance
Price areas where Redcare Pharmacy has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance€71.50+12.78%2 touches, last on July 21, 2026
- Resistance€69.09+8.97%4 touches, last on October 30, 2026
- Resistance€64.85+2.29%4 touches, last on July 23, 2026
- Last price€63.40
- Support€61.70−2.68%2 touches, last on July 31, 2026
- Support€59.75−5.76%5 touches, last on September 25, 2026
- Support€53.53−15.58%2 touches, last on June 3, 2026
Volatility and risk
Over the last year it has moved less than the DAX.
- Beta (1 year) vs DAX
- 0.66
- Volatility (60 sessions, annualised)
- 67.0%
- Largest fall in the last year
- −56.84%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Redcare Pharmacy: seasonality
Average monthly price change over 10 years
Over the last 10 years, the strongest month for Redcare Pharmacy has been May: +7.99% on average, positive in 6 years out of 10. The weakest has been February: −3.74% on average, positive in 4 years out of 10. November, the current month, has been positive in 4 years out of 10 (+0.28% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +7.45% | +0.82% | 6 of 10 |
| February | −3.74% | −3.27% | 4 of 10 |
| March | −0.75% | +0.24% | 5 of 10 |
| April | +5.49% | +3.67% | 6 of 10 |
| May | +7.99% | +0.63% | 6 of 10 |
| June | +3.73% | +1.58% | 5 of 10 |
| July | +5.40% | +7.81% | 7 of 10 |
| August | −1.69% | +2.86% | 6 of 10 |
| September | −1.82% | −7.17% | 4 of 10 |
| October | +3.88% | +3.14% | 7 of 10 |
| November | +0.28% | −4.23% | 4 of 10 |
| December | −3.04% | −0.22% | 5 of 10 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Redcare Pharmacy and its competitors
Online sales of pharmacy goods across seven European countries form the core of this company, which was founded in 2001 under the name Shop Apotheke Europe N.V. and took its current name in June 2023. Its catalogue covers medicines sold with and without a doctor's prescription, along with cosmetics, personal care lines and food supplements. The markets served are the Netherlands, Germany, Italy, Belgium, Switzerland, Austria and France, all served through its online channels.
- Headquarters
- Sevenum, Netherlands
- Employees
- 2,163
- Founded
- 2001
- Chief executive
- Schmid Linstow
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Redcare PharmacyRDC | $1.47B | 0.3% | — | +36.52% |
| Raia DrogasilRADL3 | $4.04B | 6.1% | 17.6 | −24.57% |
| Alibaba Health Information Tech0241 | $5.4B | 5.3% | 20.1 | −33.12% |
| JD Health International6618 | $13.26B | 6.1% | 15.0 | −19.27% |
| PuuiloPUUILO | $1.69B | 18.2% | 23.8 | +41.58% |
| Hagar hfHAGA | $1.07B | 6.2% | 18.1 | 0.00% |
Same industry or related industries, similar size. Compare Redcare Pharmacy with its competitors · Full profile
